Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biosimilar
Pharma
IRA biosim policy plays 'small' role in savings so far: report
The IRA features a five-year boost in Medicare reimbursement rates for biosims. The measure was intended to boost uptake, but has it worked so far?
Zoey Becker
Aug 29, 2024 1:35pm
BI taps GoodRx to offer its Humira biosim at a steep markdown
Jul 18, 2024 11:15am
Italy opens antitrust case against Novartis, Biogen and others
Jun 6, 2024 11:39am
Boehringer partners with Cigna unit to push Humira biosimilar
May 13, 2024 10:56am
Alvotech plots upcoming overseas Stelara biosim launches
Feb 16, 2024 7:20am
Sandoz breaks ground at $400M Slovenia site
Dec 13, 2023 8:46am
